BDBM63225 4-morpholinecarboxylic acid [(2Z)-2-[(4-ethylphenyl)methylidene]-3-oxo-6-benzofuranyl] ester::MLS000331649::Morpholine-4-carboxylic acid 2-[1-(4-ethyl-phenyl)-meth-(Z)-ylidene]-3-oxo-2,3-dihydro-benzofuran-6-yl ester::SMR000220675::[(2Z)-2-[(4-ethylphenyl)methylidene]-3-oxidanylidene-1-benzofuran-6-yl] morpholine-4-carboxylate::[(2Z)-2-[(4-ethylphenyl)methylidene]-3-oxo-1-benzofuran-6-yl] morpholine-4-carboxylate::cid_2018190::morpholine-4-carboxylic acid [(2Z)-2-(4-ethylbenzylidene)-3-keto-coumaran-6-yl] ester

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cc(F)cc(C(=O)OC4CCNCC4)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=AKVRTMYWOXCHIQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 63225   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63225BDBM63225(piperidin-4-yl 3-fluoro-5-(2-(3-(6-methylpyridin-2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63225BDBM63225(piperidin-4-yl 3-fluoro-5-(2-(3-(6-methylpyridin-2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent